Full-Time

Associate Director

Institutional Analytics & Forecasting

Confirmed live in the last 24 hours

Takeda

Takeda

10,001+ employees

Develops and commercializes biopharmaceuticals and vaccines

Compensation Overview

$149.1k - $234.3k/yr

+ Short-term Incentives + Long-term Incentives

Senior, Expert

Cambridge, MA, USA

This position is classified as 'hybrid' in accordance with Takeda's Hybrid and Remote Work policy.

Category
Financial Planning and Analysis (FP&A)
Finance & Banking
Required Skills
Market Research
Python
SQL
Tableau
Databricks
Excel/Numbers/Sheets
Requirements
  • Bachelor’s Degree in a technical, quantitative, or scientific discipline preferred. Master’s degree a plus
  • 8-10+ years of experience in a pharmaceutical analytics role required; experience in rare diseases a plus
  • Hands-on experience with data manipulation, exploratory data analysis, data visualization, regression-type analysis, and model interpretation to support hypothesis generation and reveal key insights required
  • Familiarity with bottom-up and top-down forecasting technics, including market, disease prevalence, incidence, market share, patient funnel and distribution channels required
  • Experience with pharmaceutical industry class of trade, site of care, commercial and government pricing environments required, understanding of payer access systems preferred
  • Solid knowledge and hands-on experience with multiple data sources such as IQVIA, Specialty Pharmacy dispense data, Biological Distributor data, and Symphony or Komodo claims required
  • Proficiency in Tableau or other data visualization platform is required for success in this role
  • Experience working with Databricks or other data intelligence platform and proficiency in Python/SQL for data management and process automation a plus
  • Experience with primary market research and competitive intelligence a plus
  • Advanced proficiency in Microsoft Excel and PowerPoint are must-haves
  • People management experience and demonstrated ability to lead without authority preferred
  • Strong interpersonal and communication skills with a collaborative mindset and team player mentality
  • High degree of learning agility and proven ability to learn new data systems with minimal formal training
  • ~10% travel for meetings and conferences.
Responsibilities
  • Be a subject matter expert on analytic methodologies and multiple data sources; Oversee advanced business analyses to deliver actionable insights to commercial senior leadership and cross-functional stakeholders on the Institutional Franchise team
  • Identify and define critical business issues and questions, define appropriate analytical approaches, identify source data, and conduct data analyses to develop deeper understanding of market and business performance
  • Create Tableau-based and other innovative analytics reporting solutions to serve recurring and ad-hoc needs related to demand and pricing dynamics across multiple channels (Biological Distributors, Specialty Pharmacies, Group Purchasing Organizations, Integrated Delivery Networks, Alternate Sites)
  • Lead regular business reviews and situation assessments for the Institutional Franchise team providing insights into the key drivers of business performance and recommended courses of action
  • Support Data Strategy & Ops team in managing data quality and hygiene
  • Collaborate with broader SI&A team for ad hoc workstreams as necessary
  • Oversee the demand forecasting for IV therapies and help coordinate demand forecasting efforts across the PDT BU for mid- and long-range forecasts:
  • Provide inputs and collaborate on developing fact-based assumptions; review and implement best practices
  • Lead scenario planning and sensitivity development for risks and opportunities with appropriate analyses
  • Ensure alignment with Finance and Franchise Heads throughout each forecasting cycle; Advise stakeholders on material variances vs. prior years or changes in assumptions
  • Monitor forecast accuracy and suggest methods to reduce forecasting errors; evaluate industry forecasting trends and incorporate enhancements as needed
  • Directly supervise, train, and mentor the Sr. Manager, Customer Analytics and Forecasting
Desired Qualifications
  • Experience in rare diseases a plus
  • Understanding of payer access systems preferred
  • Experience working with Databricks or other data intelligence platform and proficiency in Python/SQL for data management and process automation a plus
  • Experience with primary market research and competitive intelligence a plus
  • People management experience and demonstrated ability to lead without authority preferred

Takeda Pharmaceutical Company Limited is a global biopharmaceutical firm that focuses on developing and delivering treatments and vaccines. The company invests heavily in research and development to create new molecular entities (NMEs) and has a pipeline aiming for multiple product launches in the coming years. Takeda's products are designed to meet the needs of healthcare providers, hospitals, and patients around the world. What sets Takeda apart from its competitors is its strong commitment to patient-centric values and environmental sustainability, recognizing the connection between human health and environmental health. The company's goal is to innovate and provide life-changing therapies while ensuring that patient needs are prioritized.

Company Size

10,001+

Company Stage

IPO

Headquarters

Tokyo, Japan

Founded

1781

Simplify Jobs

Simplify's Take

What believers are saying

  • Takeda's collaboration with BridGene could enhance its immunology and neurology offerings.
  • The SEA AtM Summit highlights Takeda's commitment to expanding access to medicines in Asia.
  • Positive Phase III trial results for a cancer drug strengthen Takeda's oncology portfolio.

What critics are saying

  • Antitrust litigation in the US could impact Takeda's market position and reputation.
  • The $770 million deal with BridGene poses financial risks if outcomes aren't met.
  • Geopolitical risks could disrupt Takeda's global operations and supply chain.

What makes Takeda unique

  • Takeda has a 240-year history in the biopharmaceutical industry.
  • The company emphasizes patient-centric values in its operations and innovations.
  • Takeda's robust pipeline includes 11 NMEs with plans for 15 launches by FY2024.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Wellness Program

Tuition Reimbursement

Company News

MLex
Mar 4th, 2025
Meijer seeks quick appeal in US antitrust case against Takeda

( March 4, 2025, 17:06 GMT | Official Statement) - MLex Summary: Meijer asked a US federal judge for leave to immediately appeal an order that sent its antitrust case against Takeda Pharmaceuticals over the drug Amitiza to arbitration.

BioSpace
Mar 3rd, 2025
Takeda-Protagonist Drug for Incurable Cancer Reduces Need for Blood Withdrawals in Phase III Trial

Protagonist, which will receive a $25 million milestone from Takeda thanks to the positive results, plans to submit the findings to regulators.

Access Health
Mar 3rd, 2025
Strengthening Access to Medicines in Southeast Asia: Highlights from Southeast Asia Access to Medicine (SEA AtM) Summit

ACCESS Health International, in collaboration with AVPN, SingHealth Duke-NUS Global Health Institute, and Takeda, successfully co-hosted the first Southeast Asia Access to Medicine (SEA AtM) Summit in Bangkok.

Pharmaceutical Technology
Feb 25th, 2025
Takeda broadens its deal with BridGene for up to $770m

Bridgene and Takeda have inked a deal worth $770m to develop small molecules for immunology and neurology.

Nyasa Times
Feb 6th, 2025
Forgotten Children: Mzimba's Tukuyu CBCC Struggles to Provide Basic Education

VillageReach, in partnership with Takeda Pharmaceutical Company Limited, has launched a new initiative aimed at strengthening health systems and improving...